Elan | Evaluate

February 28, 2017

Lovestruck Royalty snares its prey at last

November 23, 2016

Lilly bids sola so long

August 29, 2016

ESC 2016 – Prothena builds case for amyloidosis valuation

April 26, 2016

What Papa might preach to Valeant

October 26, 2015

Valeant bargains for its life

July 21, 2015

Mid-tier players make the most efficient employers

June 22, 2015

Event – Transition to agitation the solution for Elan cast-off

May 26, 2015

Speciality players define M&A as big pharma seeks focus

April 09, 2015

Mylan anti-chain action as good as confirms Teva interest

March 23, 2015

Prothena data stimulate market tremors

March 20, 2015

Biogen clears one Alzheimer’s hurdle; now comes the tricky bit

Load More